Planet 13 Holdings (PLNH) Operating Expenses (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Operating Expenses came in at $15.1 million in Q1 2026, down 18.96% year-on-year from $18.6 million in Q1 2025, and down 4.8% on a QoQ basis from $15.9 million in Q4 2025.
Planet 13 Holdings (PLNH) Operating Expenses (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Operating Expenses data on file, last reported at $15.1 million in Q1 2026.
- On a quarterly basis, Operating Expenses fell 18.96% year-over-year to $15.1 million in Q1 2026; TTM through Mar 2026 was $95.6 million, a 0.49% change from a year earlier, with the FY2025 full-year figure at $99.2 million, up 8.22% from the prior year.
- Operating Expenses for Q1 2026 stood at $15.1 million, down from $15.9 million in the prior quarter.
- Over the last five years, Operating Expenses for PLNH reached as high as $55.1 million in Q3 2023 and fell as low as $14.1 million in Q1 2024.
- Historically, Operating Expenses has averaged $24.0 million across 5 years, with a median of $18.5 million in 2025.
- Across the five-year window, Operating Expenses jumped 268.36% in 2023 and tumbled 63.65% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $49.5 million in 2022, then plunged by 59.31% to $20.2 million in 2023, then surged by 88.92% to $38.1 million in 2024, then slumped by 58.37% to $15.9 million in 2025, then fell by 4.8% to $15.1 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $15.1 million in Q1 2026, $15.9 million in Q4 2025, and $46.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 15.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.09 Mn |
| Dec 31, 2025 | 15.85 Mn |
| Sep 30, 2025 | 46.20 Mn |
| Jun 30, 2025 | 18.48 Mn |
| Mar 31, 2025 | 18.62 Mn |
| Dec 31, 2024 | 38.08 Mn |
| Sep 30, 2024 | 20.02 Mn |
| Jun 30, 2024 | 19.38 Mn |
| Mar 31, 2024 | 14.15 Mn |
| Dec 31, 2023 | 20.16 Mn |
| Sep 30, 2023 | 55.07 Mn |
| Jun 30, 2023 | 15.38 Mn |
| Mar 31, 2023 | 15.31 Mn |
| Dec 31, 2022 | 49.53 Mn |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 15.64 Mn |
| Mar 31, 2022 | 16.61 Mn |
| Dec 31, 2021 | 13.74 Mn |
| Sep 30, 2021 | 24.67 Mn |
| Jun 30, 2021 | 20.38 Mn |